Skip to content
healthcare.dev

HydrALAZINE Hydrochloride

NDC 76282-311, HydrALAZINE Hydrochloride, tablet, from Exelan Pharmaceuticals Inc..

Product NDC
76282-311
Status
Listed
Labeler
Exelan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090255
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE50 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
76282-311-0176282031101100 TABLET in 1 BOTTLE (76282-311-01)
76282-311-10762820311101000 TABLET in 1 BOTTLE (76282-311-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/811831f9-a844-463a-874d-fb8407659f0b
  • NADAC price for package 76282031101

    GET /v1/drugs/nadac/76282031101
  • NADAC price for package 76282031110

    GET /v1/drugs/nadac/76282031110

Use it

Look up 76282-311 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.